Basma Adeem Medical Co.
9626.SR
Saudi Exchange6.00
SAR
- -
- -
Basma Adeem Medical Co.
9626.SR
(Saudi Exchange)
Recent
price
6.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Basma Adeem Medical Co. (9626.SR), doing business as Smile Care, provides dental and dermatology services in Saudi Arabia; its core offerings encompass one-day surgery, orthodontics and maxillofacial surgery, periodontal surgery and dental implants, root canal treatments and endodontics, oral and dental health care, dental repair and cosmetic dentistry, prosthodontics, pediatric dentistry, preventive restorations, oral surgery, laser treatments for skin conditions, teeth whitening, veneers, gum depigmentation, dental scaling, fillings, and clear aligners. The company operates specialized clinics targeting patients seeking comprehensive oral health, cosmetic enhancements, and dermatological solutions, with a focus on high-quality preventive and corrective treatments delivered by experienced Saudi and international specialists. Founded on November 13, 2012, and headquartered on King Abdulaziz Branch Road in Al Yasmeen District, Riyadh, Basma Adeem Medical Co. serves the Kingdom's healthcare market through multiple branches. In recent developments, the company listed on the Nomu parallel market of the Saudi Stock Exchange on February 3, 2025, at SAR 4.40 per share, raising funds through its initial public offering; it opened a second dental clinic in Riyadh in July 2025, secured a SAR 3.87 million contract with the King Abdullah Financial District (KAFD) in August 2025, and obtained a Health Ministry license for its dermatology department at the Riyadh branch in October 2025. These expansions support ongoing profit growth, including a 7.3% rise to SAR 2.6 million in H1 2025 and 29% to SAR 6.3 million for full-year 2024.